Parkinson's disease overview, treatment options, including deep brain stimulation, and future developments in neurosurgery by ...
Someone will call and say, ‘I was just told I have Parkinson’s disease in a 20-minute visit with my doctor, and I don’t know ...
GlobalData on MSN12h
Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setbackThe pivotal, Phase III study will evaluate the change in average daily “OFF” time in solengepras patients compared to placebo ...
Holtzinger thanked her health team, which includes neurologist Dr. Anthony May and neurosurgeon Dr. Joel Winer. "When ...
Irish Examiner on MSN1d
'Too young to be here': Parkinson’s patient, 47, trapped in Cork nursing home due to lack of State supportWith no alternative care options, young Parkinson’s patients like Colm O’Catháin are left to fade away in nursing homes ...
Cerevance’s attempt to unlock the first-line Parkinson's disease market has hit a snag, with solengepras performing no better ...
Leading scientists at the National Institutes of Health, the US’s leading medical research agency, were swept up Tuesday in ...
Shaynee ModienLocal Journalism Initiative ReporterThe Shaunavon StandardAround the World, April is Parkinson's Awareness ...
Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other ...
Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback